USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Increasing Demand for Consumables and Single-use Technologies to Drive Growth in Upstream Bioprocessing
27-Aug-2021
North America
Market Research
MG3C-01-00-00-00
HC03445-NA-MT_25726
The Transformational Health team at Frost & Sullivan provides critical insights into the US and EU upstream bioprocessing market, highlighting drug demand trends, installed capacity developments, market revenue forecast by various segments, competitive landscape, and key growth opportunities that currently exist or are set to develop during the forecast period. The study segments the market by upstream segment of bioprocessing (media preparation systems and consumables and bioreactors—stainless steel and single use) and region (the United States and European Union). Frost & Sullivan delivers the market forecast and breakdown by various segments from 2020 to 2026 in this study, and the key underling factors that are set to influence the growth of the overall market.
Research Highlights
- Biologics drug development pipeline and capacity expansion plans of biologics Contract Development and Manufacturing Organizations (CDMOs) and biopharmaceutical companies
- Installed capacity breakdown by region
- Pros and cons of stainless steel bioreactors and single use bioreactors
- Key acquisitions, investments, and collaborations in the bioprocessing industry
- Facility design considerations and innovations in expression systems
- Growth opportunities centering on single-use technologies, process optimization, and media and supplements
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top Three Strategic Imperatives on the US and EU Bioprocessing Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Scope of Analysis
Market Segmentation
Key Growth Metrics for the US and EU Upstream Bioprocessing Market
Growth Drivers for the Upstream Bioprocessing Market
Growth Restraints for the Upstream Bioprocessing Market
Key Competitors and Vendor Landscape of Bioprocessing Industry
Biopharmaceutical Industry Overview
Biological Drug Development Pipeline, 2021
Biological Drug Development Pipeline Analysis, 2021
Bio-Contract Development and Manufacturing Organizations (Bio-CDMOs)
Recent Capacity Expansion Plans—Upstream Bioprocessing Market
Forecast Framework—Bio-processing Market
Forecast Methodology—Upstream Bioprocessing Market
Forecast Assumptions and Considerations—Upstream Bioprocessing Market
Quantity Demand Forecast—Mammalian Cell Culture Based Drugs
Quantity Demand Forecast Analysis—Mammalian Cell Culture-based Drugs
Capacity Requirement to Meet Volume Demand Forecast—Mammalian Cell Culture-based Drug Manufacturing
Capacity Requirement to Meet Volume Demand Forecast Analysis—Mammalian Cell Culture-based Drug Manufacturing
Installed Capacity of Biomanufacturing—US and EU
Installed Capacity Analysis of Biomanufacturing—US and EU
Installed Capacity of Biomanufacturing by Region—US and EU
Installed Capacity Analysis of Biomanufacturing by Region—US and EU
Revenue Forecast—Upstream Bioprocessing Market: US and EU
Revenue Forecast—Media Preparation Systems and Consumables Segment: US and EU
Revenue Forecast Analysis—Media Preparation Systems and Consumables Segment: US and EU
Revenue Forecast—Bioreactor Segment: US and EU
Revenue Forecast Analysis—Bioreactor Segment: US and EU
Revenue Forecast—Stainless Steel Bioreactor Systems: US and EU
Revenue Forecast Analysis—Stainless Steel Bioreactor Systems: US and EU
Revenue Forecast—Single-use Bioreactor Systems: US and EU
Revenue Forecast Analysis—Single Use Bioreactor Systems: US and EU
Stainless Steel Bioreactor Systems Versus Single-use Bioreactor Systems
Cost of Manufacturing in Upstream Bioprocessing
Competitive Environment—Upstream Bioprocessing Market
Top Market Participants—Upstream Bioprocessing Market
Some of the Key Acquisitions in the Bioprocessing Industry
Business Models in the Bioprocessing Industry
Key Investments and Collaborations in the Bioprocessing Industry
Design Considerations—Bioprocessing Facilities
Comparative Analysis of Different Facility Types
Emerging and Exciting Innovations in Biomanufacturing
Growth Opportunity 1: Single-use Technology in Manufacturing Standardization of Next-generation Biologics
Growth Opportunity 1: Single-use Technology in Manufacturing Standardization of Next-generation Biologics (continued)
Growth Opportunity 2: Cell Retention Technologies for Process Intensification
Growth Opportunity 2: Cell Retention Technologies for Process Intensification (continued)
Growth Opportunity 3: Innovations in Serum-free Media and Supplements for Boosting Cell Growth
Growth Opportunity 3: Innovations in Serum-free Media and Supplements for Boosting Cell Growth (continued)
Your Next Steps
Why Frost, Why Now?
List of Exhibits
List of Exhibits (continued)
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Research Highlights
- Biologics drug development pipeline and capacity expansion plans of biologics Contract Development and Manufacturing Organizations (CDMOs) and biopharmaceutical companies
- Installed capacity breakdown by region
- Pros and cons of stainless steel bioreactors and single use bioreactors
- Key acquisitions, investments, and collaborations in the bioprocessing industry
- Facility design considerations and innovations in expression systems
- Growth opportunities centering on single-use technologies, process optimization, and media and supplements
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Unmesh Lal |
| Industries | Healthcare |
| WIP Number | MG3C-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9600-B1,9571-B1,9568-B1,9611-B1 |
US and EU Upstream Bioprocessing Growth Opportunities
$4,950.00
Special Price $3,712.50 save 25 %